Us Pharmaceuticals
- All
- News
- Videos
-
Mumbai-Born US CEO Reshma Kewalramani Named In TIME's 2025 Influential List
Reshma Kewalramani, the Indian-origin CEO of US-based Vertex Pharmaceuticals, has been named on the list of "100 Most Influential People" of 2025 by Time Magazine.
-
Trump Sets Stage For New Tariffs With Probe Into Pharma, Chip Imports
Amid US President Donald Trump's fresh tariff threats, the federal government in America has opened an investigation into the effects of importing certain pharmaceuticals and semiconductors on national security.
-
US Opens Door To Tariffs On Pharma, Semiconductors
The United States opened the door Monday to tariffs targeting high-end technology and pharmaceuticals, feeding the uncertainty gripping the global economy in a trade war that Chinese leader Xi Jinping warned can have "no winner."
-
Sensex, Nifty Open In Red Ahead Of Repo Rate Announcement
Indian equity indices opened in the red on Wednesday, following its global peers, as US President Donald Trump threatened reciprocal tariffs on the global pharmaceutical sector.
-
New Trouble For India? Trump Says US Will Tariff Pharmaceutical Imports Soon
Continuing his economic onslaught, US President Donald Trump said on Tuesday that Washington is planning to announce a "major" tariff on pharmaceutical imports soon.
-
Pharma, Semi-conductors, Energy Products Exempted From Trump's Tariff
Essential and strategic items such as pharmaceuticals, semiconductors, copper, and energy products like oil, gas, coal and LNG are exempted from the 26 per cent import duty announced by the US on Wednesday, according to think tank GTRI.
-
Here Are Trump's Reciprocal Tariffs By Country. Topping List At 50% Are...
Certain goods from key industries - including steel, aluminum, automobiles, copper, pharmaceuticals, semiconductors, and lumber - are exempt from these rates.
-
"Crucial Milestone": US Approves New Antibiotic For Urinary Tract Infections
The product -- called Blujepa -- was approved for the treatment of uncomplicated urinary tract infections in adult women and girls 12 and older.
-
15 Lakh Bottles Of ADHD Medication Recalled In U.S. By Glenmark
ADHD is seen as a chronic and incapacitating disorder that affects a person's everyday functioning.
-
Donald Trump Plans To Impose New Tariffs "Over Next Month". What's On Target
US President Donald Trump is planning to announce tariffs on more products as he pushes to shrink America's trade deficits, boost domestic manufacturing and achieve other policy goals.
-
Johnson & Johnson Risks UK Lawsuit Over Powder Cancer Claim By Thousands
UK claimants on Wednesday announced legal action against US pharmaceutical and cosmetics giant Johnson & Johnson, alleging that women diagnosed with cancers were exposed to asbestos in the company's talcum powder.
-
"Trump's Win Beneficial For India's Export Trade": Economist Suriya Narayanan
India has an opportunity to export more goods to the US, including agro and pharmaceutical goods, said Indian Economist Suriya Narayan.
-
Trump's 'America First' Agenda May Lead To Tighter H-1B Visa Rules: Experts
With Donald Trump all set to become US president, Indian exporters may face high customs duties for goods like automobiles, textiles and pharmaceuticals if the new US administration decides to pursue the America First' agenda, opined trade experts.
-
Indian National Charged With Selling Counterfeit Pharmaceuticals In US
A US court on Thursday charged Sanjay Kumar from Bihar with selling and shipping tens of thousands of dollars' worth of counterfeit oncology pharmaceuticals into the country.
-
Johnson & Johnson To Pay $700 Million In Talc Safety Settlement
US pharmaceutical and cosmetics giant Johnson & Johnson has agreed to pay $700 million to settle allegations it misled customers about the safety of its talcum-based powder products, New York's attorney general announced Tuesday.
-
Mumbai-Born US CEO Reshma Kewalramani Named In TIME's 2025 Influential List
Reshma Kewalramani, the Indian-origin CEO of US-based Vertex Pharmaceuticals, has been named on the list of "100 Most Influential People" of 2025 by Time Magazine.
-
Trump Sets Stage For New Tariffs With Probe Into Pharma, Chip Imports
Amid US President Donald Trump's fresh tariff threats, the federal government in America has opened an investigation into the effects of importing certain pharmaceuticals and semiconductors on national security.
-
US Opens Door To Tariffs On Pharma, Semiconductors
The United States opened the door Monday to tariffs targeting high-end technology and pharmaceuticals, feeding the uncertainty gripping the global economy in a trade war that Chinese leader Xi Jinping warned can have "no winner."
-
Sensex, Nifty Open In Red Ahead Of Repo Rate Announcement
Indian equity indices opened in the red on Wednesday, following its global peers, as US President Donald Trump threatened reciprocal tariffs on the global pharmaceutical sector.
-
New Trouble For India? Trump Says US Will Tariff Pharmaceutical Imports Soon
Continuing his economic onslaught, US President Donald Trump said on Tuesday that Washington is planning to announce a "major" tariff on pharmaceutical imports soon.
-
Pharma, Semi-conductors, Energy Products Exempted From Trump's Tariff
Essential and strategic items such as pharmaceuticals, semiconductors, copper, and energy products like oil, gas, coal and LNG are exempted from the 26 per cent import duty announced by the US on Wednesday, according to think tank GTRI.
-
Here Are Trump's Reciprocal Tariffs By Country. Topping List At 50% Are...
Certain goods from key industries - including steel, aluminum, automobiles, copper, pharmaceuticals, semiconductors, and lumber - are exempt from these rates.
-
"Crucial Milestone": US Approves New Antibiotic For Urinary Tract Infections
The product -- called Blujepa -- was approved for the treatment of uncomplicated urinary tract infections in adult women and girls 12 and older.
-
15 Lakh Bottles Of ADHD Medication Recalled In U.S. By Glenmark
ADHD is seen as a chronic and incapacitating disorder that affects a person's everyday functioning.
-
Donald Trump Plans To Impose New Tariffs "Over Next Month". What's On Target
US President Donald Trump is planning to announce tariffs on more products as he pushes to shrink America's trade deficits, boost domestic manufacturing and achieve other policy goals.
-
Johnson & Johnson Risks UK Lawsuit Over Powder Cancer Claim By Thousands
UK claimants on Wednesday announced legal action against US pharmaceutical and cosmetics giant Johnson & Johnson, alleging that women diagnosed with cancers were exposed to asbestos in the company's talcum powder.
-
"Trump's Win Beneficial For India's Export Trade": Economist Suriya Narayanan
India has an opportunity to export more goods to the US, including agro and pharmaceutical goods, said Indian Economist Suriya Narayan.
-
Trump's 'America First' Agenda May Lead To Tighter H-1B Visa Rules: Experts
With Donald Trump all set to become US president, Indian exporters may face high customs duties for goods like automobiles, textiles and pharmaceuticals if the new US administration decides to pursue the America First' agenda, opined trade experts.
-
Indian National Charged With Selling Counterfeit Pharmaceuticals In US
A US court on Thursday charged Sanjay Kumar from Bihar with selling and shipping tens of thousands of dollars' worth of counterfeit oncology pharmaceuticals into the country.
-
Johnson & Johnson To Pay $700 Million In Talc Safety Settlement
US pharmaceutical and cosmetics giant Johnson & Johnson has agreed to pay $700 million to settle allegations it misled customers about the safety of its talcum-based powder products, New York's attorney general announced Tuesday.
